Zobrazeno 1 - 10 of 340 pro vyhledávání: '"L. L. Gordon"'
1
Development of verbatim and gist memory for numbers
Autor: Charles J. Brainerd, L. L. Gordon
Publikováno v: Developmental Psychology. 30:163-177
Two theories of developmental and functional relationships between verbatim and gist memories of numbers were compared: (a) the integration hypothesis, which assumes that gist memories are constructive inferences from verbatim memories, and (b) the p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::47e1eab8fd2815be9011cfd74e7db831
https://doi.org/10.1037/0012-1649.30.2.163
Zobrazit plný text záznamu
2
The development of a clinically relevant canine model of postperfusion syndrome
Autor: R T, Baldwin, K A, Kadipasaoglu, B, Radovancevic, L L, Gordon, N, Furusho, R, Matsuwaka, J L, Conger, S M, Parnis, W D, Hare, F J, Clubb
Publikováno v: ASAIO transactions. 37(3)
Investigation into the complex etiology of the postperfusion syndrome (PPS) has been limited by access to only retrospective human case studies, and performance of animal studies that examine biochemical predictors of injury rather than the PPS itsel
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::81d35fddaffc9e84d1d4f8ba4855c971
https://pubmed.ncbi.nlm.nih.gov/1751245
Zobrazit plný text záznamu
3
Comparative low-dose nephrotoxicities of gentamicin, tobramycin, and amikacin
Autor: G H Hottendorf, L L Gordon
Publikováno v: Antimicrobial Agents and Chemotherapy. 18:176-181
Most investigations of the comparative nephrotoxicities of aminoglycosides in animals have utilized large multiples of the human dose. Furthermore, many of these assessments have used only one or two dose levels and have not described a dose-response
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eaa9deaf5283dde94b06a0bb02521b6
https://doi.org/10.1128/aac.18.1.176
Zobrazit plný text záznamu
5
Analgesic activity of butorphanol in horses: dosage titration and clinical studies
Autor: D. A. Gingerich, P. W. Strom, J. E. Rourke, L. L. Gordon, M. Kalpravidh
Publikováno v: Comparative Veterinary Pharmacology, Toxicology and Theraphy ISBN: 9789401083430
Butorphanol is a synthetic opiate of the cyclorphan series which possesses both narcotic agonist and antagonist properties. The drug has been characterized pharmacologically and clinically in humans as an analgesic and as a component of balanced anae
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4112e712ffd4a721220277ae5a8d03f1
https://doi.org/10.1007/978-94-009-4153-3_4
Zobrazit plný text záznamu
6
Butorphanol/acetaminophen double-blind study in postoperative pain
Autor: R E, Young, J J, Quigley, W A, Archambault, L L, Gordon
Publikováno v: Journal of medicine. 10(4)
An oral butorphanol/acetaminophen (4 mg/650 mg) combination product was evaluated for analgesic activity in 120 postoperative patients employing a double-blind experimental design. The combination product was significantly (p less than 0.05) superior
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3d8d56d3a5c9d94b0f931859f8cce7ab
https://pubmed.ncbi.nlm.nih.gov/393788
Zobrazit plný text záznamu
7
Nonparallel nephrotoxicity dose-response curves of aminoglycosides
Autor: H. Madissoo, L L Gordon, E F Christensen, G. H. Hottendorf, Barnett D
Nephrotoxicity comparisons of aminoglycosides in rats, utilizing large multiples of human doses, have indicated an advantage for netilmicin. However, no nephrotoxicity advantage of netilmicin has been demonstrated at the lower doses used in clinics.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d409b0740d704530eed467b7b4c22b9
https://europepmc.org/articles/PMC181601/
Zobrazit plný text záznamu
10
Kappa Opioid Receptors in Mesolimbic Terminals Mediate Escalation of Cocaine Consumption.
Autor: Gordon-Fennell L; Graduate Program in Neuroscience, University of Washington, Seattle, WA 98195.; Center for Neurobiology of Addiction, Pain & Emotion, University of Washington, Seattle, WA 98195.; Department of Psychiatry & Behavioral Science, University of Washington, Seattle, WA 98195., Farero RD; Graduate Program in Neuroscience, University of Washington, Seattle, WA 98195.; Center for Neurobiology of Addiction, Pain & Emotion, University of Washington, Seattle, WA 98195.; Department of Psychiatry & Behavioral Science, University of Washington, Seattle, WA 98195., Burgeno LM; Center for Neurobiology of Addiction, Pain & Emotion, University of Washington, Seattle, WA 98195.; Department of Psychiatry & Behavioral Science, University of Washington, Seattle, WA 98195.; Department of Pharmacology, University of Washington, Seattle, WA 98195., Murray NL; Center for Neurobiology of Addiction, Pain & Emotion, University of Washington, Seattle, WA 98195.; Department of Psychiatry & Behavioral Science, University of Washington, Seattle, WA 98195., Abraham AD; Center for Neurobiology of Addiction, Pain & Emotion, University of Washington, Seattle, WA 98195.; Department of Pharmacology, University of Washington, Seattle, WA 98195., Soden ME; Center for Neurobiology of Addiction, Pain & Emotion, University of Washington, Seattle, WA 98195.; Department of Pharmacology, University of Washington, Seattle, WA 98195., Stuber GD; Graduate Program in Neuroscience, University of Washington, Seattle, WA 98195.; Center for Neurobiology of Addiction, Pain & Emotion, University of Washington, Seattle, WA 98195.; Department of Psychiatry & Behavioral Science, University of Washington, Seattle, WA 98195.; Department of Pharmacology, University of Washington, Seattle, WA 98195.; Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA 98195., Chavkin C; Graduate Program in Neuroscience, University of Washington, Seattle, WA 98195.; Center for Neurobiology of Addiction, Pain & Emotion, University of Washington, Seattle, WA 98195.; Department of Pharmacology, University of Washington, Seattle, WA 98195., Zweifel LS; Graduate Program in Neuroscience, University of Washington, Seattle, WA 98195.; Center for Neurobiology of Addiction, Pain & Emotion, University of Washington, Seattle, WA 98195.; Department of Psychiatry & Behavioral Science, University of Washington, Seattle, WA 98195.; Department of Pharmacology, University of Washington, Seattle, WA 98195., Phillips PEM; Graduate Program in Neuroscience, University of Washington, Seattle, WA 98195.; Center for Neurobiology of Addiction, Pain & Emotion, University of Washington, Seattle, WA 98195.; Department of Psychiatry & Behavioral Science, University of Washington, Seattle, WA 98195.; Department of Pharmacology, University of Washington, Seattle, WA 98195.
Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2023 Dec 23. Date of Electronic Publication: 2023 Dec 23.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje